chr12-39760159-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_052885.4(SLC2A13):āc.1814T>Cā(p.Ile605Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,612,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_052885.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A13 | NM_052885.4 | c.1814T>C | p.Ile605Thr | missense_variant | 10/10 | ENST00000280871.9 | NP_443117.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A13 | ENST00000280871.9 | c.1814T>C | p.Ile605Thr | missense_variant | 10/10 | 1 | NM_052885.4 | ENSP00000280871.4 | ||
C12orf40 | ENST00000468200.2 | n.*725-4581A>G | intron_variant | 1 | ENSP00000473371.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151958Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250358Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135296
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1460876Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726742
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151958Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74214
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.1814T>C (p.I605T) alteration is located in exon 10 (coding exon 10) of the SLC2A13 gene. This alteration results from a T to C substitution at nucleotide position 1814, causing the isoleucine (I) at amino acid position 605 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at